To confirm our previous observation we have evaluated the efficacy of eradication therapy in 21 consecutive, newly diagnosed, H. pylori positive ITP patients (11 males and 10 females, median age 55.1 years [range 25-73 years]). We followed these patients between January 2000 and July 2003 (median follow up 18.1 months, range 10-42 months) and we never administered immunosuppressive drugs. H. pylori infection was assessed by urea breath test and HIV, HCV positivity or other underlying autoimmune diseases were excluded.
Helicobacter pylori infection and idiopathic thrombocytopenic purpura: description of 21 newly diagnosed cases.
KRAMPERA, Mauro;
2004-01-01
Abstract
To confirm our previous observation we have evaluated the efficacy of eradication therapy in 21 consecutive, newly diagnosed, H. pylori positive ITP patients (11 males and 10 females, median age 55.1 years [range 25-73 years]). We followed these patients between January 2000 and July 2003 (median follow up 18.1 months, range 10-42 months) and we never administered immunosuppressive drugs. H. pylori infection was assessed by urea breath test and HIV, HCV positivity or other underlying autoimmune diseases were excluded.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
